Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Guanazodine sulfate monohydrate
RN: 42839-36-1
UNII: JB96650P09
InChIKey: FKAIWDBDCWVRIG-UHFFFAOYSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formulas

  • C9-H20-N4.H2-O4-S
  • C9-H20-N4.H2-O4-S.H2-O

Molecular Weight

  • 282.3628
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Guanazodine sulfate monohydrate

Name of Substance

  • Guanazodine sulfate anhydrous

Synonyms

  • ((Octahydro-2-azocinyl)methyl)guanidine sulfate hydrate
  • Calnegyt
  • Egyt 739
  • Guanazodine sulfate monohydrate
  • NSC 303851
  • Sanegyt
  • UNII-JB96650P09

Systematic Name

  • Guanidine, ((octahydro-2-azocinyl)methyl)-, sulfate, hydrate

Registry Numbers

CAS Registry Number

  • 42839-36-1

FDA UNII

  • JB96650P09

Related Registry Number

  • 32059-15-7 (Parent)

System Generated Number

  • 0042839361

Molecular Formulas

Molecular Formulas

  • C9-H20-N4.H2-O4-S
  • C9-H20-N4.H2-O4-S.H2-O

Molecular Formula Fragments

  • C9-H20-N4
  • COMPONENT
  • H2-O
  • H2-O4-S

Structure Descriptors

InChI

1S/C9H20N4.H2O4S/c10-9(11)13-7-8-5-3-1-2-4-6-12-8;1-5(2,3)4/h8,12H,1-7H2,(H4,10,11,13);(H2,1,2,3,4)

InChIKey

FKAIWDBDCWVRIG-UHFFFAOYSA-N

Smiles

C1CCCNC(CC1)CNC(=N)N.OS(=O)(=O)O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intramuscular 1240mg/kg (1240mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 14, Pg. 235, 1977.
mouse LD50 intravenous 100mg/kg (100mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
Oyo Yakuri. Pharmacometrics. Vol. 14, Pg. 235, 1977.
mouse LD50 oral 2450mg/kg (2450mg/kg)   United States Patent Document. Vol. #3856778,
mouse LD50 subcutaneous 700mg/kg (700mg/kg)   United States Patent Document. Vol. #3856778,
rat LD50 intramuscular 1080mg/kg (1080mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
Oyo Yakuri. Pharmacometrics. Vol. 14, Pg. 235, 1977.
rat LD50 intraperitoneal 970mg/kg (970mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Oyo Yakuri. Pharmacometrics. Vol. 14, Pg. 235, 1977.
rat LD50 intravenous 136mg/kg (136mg/kg) BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 72, Pg. 837, 1976.
rat LD50 oral 3550mg/kg (3550mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
Oyo Yakuri. Pharmacometrics. Vol. 14, Pg. 235, 1977.